Clinical Endoscopy,

Author Interview

Kyeong Ok Kim
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, South Korea
Welcome to the Clinical Endoscopy Author Interview. This time, the Editorial Board will interview the author of the most cited article, Dr. Kyeong Ok Kim. Dr. Micheal Gluck and Dr. Kim have published a review article titled “Fecal Microbiota Transplantation: An Update on Clinical Practice” in March 2019. It is also one of the most read articles in Clinical Endoscopy.
Q1. Congratulations on your article being the most cited article since 2019. It is a review article on fecal microbiota transplantation (FMT). What made you write this review article?

A) Thank you. It is my great honor. Prior to overseas study in 2017, I had no clinical experience with FMT. Thanks to Dr. Michael Gluck, I had a great opportunity to study and evaluate cost and scheduling efficiency of FMT. Dr. Gluck and I have published the study results in Digestive Disease Week 2018 as an abstract and in a scientific journal as an original article. After returning to Korea, Editorial Board of Clinical Endoscopy invited me to write a review article on FMT with a focus on updates.

Q2. How did you get Dr. Gluck involved in this review?

A) After the invitation from Clinical Endoscopy, I have been searching literature and reviewing my own experience with FMT. I thought that it would be more educational and clinically applicable to have an expert in FMT as a corresponding author. And there was no better expert than Dr. Gluck in the field of FMT.

Q3. What is the main objective of this review?

A) Dr. Gluck and I have endeavored to make preparation and procedure of FMT easily understood even by beginners. We have tried to be practical and clinically applicable.

Q4. For those who are not familiar with FMT, would you explain what FMT is and what are the indications?

A) FMT is defined as the infusion of stool from a healthy individual to a patient with presumed gut dysbiosis. By infusing the stool, the gut of patients could be repopulated and restored the normal gut function. And it could be a treatment of disease associated with gut dysbiosis. Examples of gut dysbiosis are Clostridium difficile infection (CDI), inflammatory bowel disease (IBD), autoimmune disorders, certain allergic diseases, and metabolic disorders such as obesity.

Q5. What would you like to say to the readers of the review article?

A) I hope that the readers will have the general understanding of FMT. With widespread establishment of stool banks soon, FMT will be simpler. Until then, the physician needs to procure donor and prepare donor stool for infusion. Therefore, the practical protocol based on real life situation in each participating institution must be prepared. The protocol should follow the current guidelines regarding appropriate indications, rigorous donor screening criteria, stool processing and pre and post procedure patients care. In addition, the physician always needs to stay updated on the new information and knowledge for the unknown long-term safety concern.

Editorial Board of Clinical Endoscopy truly appreciates Dr. Kim’s contribution and will continue to deliver informative articles for doctors and other healthcare personnel who are involved in endoscopic procedures.